Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001663577-24-000059
Filing Date
2024-02-21
Accepted
2024-02-20 21:37:14
Documents
39
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 abti10q3a_123123.htm   iXBRL 10-Q/A 671239
7 GRAPHIC image_001.jpg GRAPHIC 2736
8 ex31_1.htm EX-31.1 9060
9 ex31_2.htm EX-31.2 9260
10 ex32_1.htm EX-32.1 5791
  Complete submission text file 0001663577-24-000059.txt   2849371

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abti-20231231.xsd EX-101.SCH 24106
3 XBRL CALCULATION FILE abti-20231231_cal.xml EX-101.CAL 33569
4 XBRL DEFINITION FILE abti-20231231_def.xml EX-101.DEF 65212
5 XBRL LABEL FILE abti-20231231_lab.xml EX-101.LAB 182003
6 XBRL PRESENTATION FILE abti-20231231_pre.xml EX-101.PRE 143470
41 EXTRACTED XBRL INSTANCE DOCUMENT abti10q3a_123123_htm.xml XML 287210
Mailing Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR
Business Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR 44 151 601 9477
ALTEROLA BIOTECH INC. (Filer) CIK: 0001442999 (see all company filings)

EIN.: 821317032 | Fiscal Year End: 0331
Type: 10-Q/A | Act: 34 | File No.: 333-156091 | Film No.: 24656208
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)